Therefore, GR expression profiles in ACC indicate that GR would be considered a prognostic and biological biomarker to stratify patients into low- or high-risk subgroups to provide rational follow-up procedures and treatment stratification based on patients’ GR signature. Here, NR3C1 is linked to adrenal cortex carcinoma.